Kintegral Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,213
| Closed | -$442K | – | 266 |
|
|
2022
Q3 | $442K | Hold |
5,213
| – | – | 0.06% | 222 |
|
|
2022
Q2 | $432K | Buy |
5,213
+110
| +2% | +$9.12K | 0.06% | 227 |
|
|
2022
Q1 | $393K | Buy |
5,103
+114
| +2% | +$8.78K | 0.04% | 247 |
|
|
2021
Q4 | $441K | Hold |
4,989
| – | – | 0.05% | 238 |
|
|
2021
Q3 | $386K | Hold |
4,989
| – | – | 0.05% | 244 |
|
|
2021
Q2 | $416K | Hold |
4,989
| – | – | 0.05% | 247 |
|
|
2021
Q1 | $377K | Hold |
4,989
| – | – | 0.05% | 251 |
|
|
2020
Q4 | $437K | Hold |
4,989
| – | – | 0.06% | 232 |
|
|
2020
Q3 | $380K | Sell |
4,989
-161
| -3% | -$12.3K | 0.06% | 225 |
|
|
2020
Q2 | $635K | Hold |
5,150
| – | – | 0.1% | 170 |
|
|
2020
Q1 | $435K | Buy |
5,150
+577
| +13% | +$48.7K | 0.08% | 197 |
|
|
2019
Q4 | $387K | Hold |
4,573
| – | – | 0.07% | 229 |
|
|
2019
Q3 | $308K | Hold |
4,573
| – | – | 0.06% | 254 |
|
|
2019
Q2 | $392K | Hold |
4,573
| – | – | 0.08% | 224 |
|
|
2019
Q1 | $406K | Buy |
4,573
+205
| +5% | +$18.2K | 0.09% | 210 |
|
|
2018
Q4 | $372K | Buy |
+4,368
| New | +$372K | 0.11% | 163 |
|